Pharmadrug Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHRX.CN research report →
Companywww.pharmadrug.ca
Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs.
- CEO
- David Kideckel
- IPO
- 2012
- Employees
- 9
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $1.08M
- P/E
- -2.82
- P/S
- 0.00
- P/B
- -0.61
- EV/EBITDA
- -13.55
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 23.86%
- ROIC
- -144.27%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-383,377 · 51.67%
- EPS
- $-0.00 · 52.63%
- Op Income
- $-225,933
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.03
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 0.67
- Avg Volume
- 69.31K
Get TickerSpark's AI analysis on PHRX.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PHRX.CN Coverage
We haven't published any research on PHRX.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PHRX.CN Report →